(Q38921915)

7 September 2017

title

Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway (English)

1 reference

7 September 2017

0 references

1 reference

Cuixia Yang

1

1 reference

7 September 2017

Linyan He

2

1 reference

7 September 2017

Pingqing He

3

1 reference

7 September 2017

Yiwen Liu

4

1 reference

7 September 2017

Wenjuan Wang

5

1 reference

7 September 2017

Yiqing He

6

1 reference

7 September 2017

Yan Du

7

1 reference

7 September 2017

Feng Gao

8

1 reference

7 September 2017

publication date

9 January 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

32

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

352

1 reference

Creating immune privilege: active local suppression that benefits friends, but protects foes.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Mutations in apoptosis genes: a pathogenetic factor for human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Role of tumor-associated macrophages in tumor progression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Importance of direct macrophage-tumor cell interaction on progression of human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0352-6

Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cyt

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25572805

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cancer: Macrophages limit chemotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25572805

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25572805

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-014-0352-6

1 reference

Dimensions Publication ID

7 September 2017

1024953161

0 references

1 reference